Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)	Common Stock	Common stock to be issued	Additional Paid-in Capital	Retained Earnings	Accumulated other comprehensive (loss) income	Non-controlling Interest	Preferred stock	Total
Balance at Dec. 31, 2019	$ 199,418	$ 7,018,942	$ 53,699,861	$ (66,300,687)	$ 42,597	$ (960,202)		$ 6,300,071
Balance (in Shares) at Dec. 31, 2019	199,418,592	7,018,942,195
Loss from disposal of NCI						67,712		67,712
Net loss for the period				(2,275,071)		(402,584)		(2,677,655)
Foreign currency translation adjustment					(9,702)	1,394		(8,308)
Balance at Mar. 31, 2020	$ 199,418	$ 7,018,942	53,699,861	(68,575,758)	32,785	(1,293,680)		(8,918,322)
Balance (in Shares) at Mar. 31, 2020	199,418,592	7,018,942,195
Balance at Dec. 31, 2020	$ 172,883		61,700,634	(73,020,134)	(13,246)	(877,585)	$ 532	(12,036,916)
Balance (in Shares) at Dec. 31, 2020	172,883,475						531,600
Issuance of shares for director’s remuneration	$ 8,333		491,667					500,000
Issuance of shares for director’s remuneration (in Shares)	8,333,335
Common stock issued upon conversion of debt	$ 12,453		91,714					104,167
Common stock issued upon conversion of debt (in Shares)	12,452,413
Fractional shares from reverse split (in Shares)	800
Net loss for the period				(228,902)		(2,324)		(231,226)
Foreign currency translation adjustment					23,219			23,219
Balance at Mar. 31, 2021	$ 193,669		$ 62,284,015	$ (73,249,036)	$ 9,973	$ (879,909)	$ 532	$ (11,640,756)
Balance (in Shares) at Mar. 31, 2021	193,670,023						531,600